章旭耀

生物药物学, 青年研究员



姓名
章旭耀
性别
男

职称
青年研究员
学历
博士

电话

传真


电子邮件
xuyaozhang@fudan.edu.cn
个人主页
https://www.researchgate.net/profile/Xuyao_Zhang

通讯地址
上海市张衡路826号复旦大学药学院


教育经历
2015.9 – 2018.7复旦大学药学院博士2012.9 – 2015.7郑州大学药学院硕士
2008.9 – 2012.7郑州大学药学院本科

工作经历
2020.9 – 至今复旦大学生物药物学系青年研究员2018.7 – 2020.8宾夕法尼亚大学肿瘤生物学博士后

承担科研项目情况
复旦大学引进人才科研基金 （2020-2023，主持）

获奖及荣誉
2018 上海市普通高等学校优秀毕业生European Society for Medical Oncology (ESMO) Immuno Oncology Congress 2017. Poster Discussion & Travel Award
2017 宝钢教育奖学金特等奖
2017 Japanese Society of Medical Oncology (JSMO) Annual Meeting. Oral Presentation & Travel Award
European Society for Medical Oncology (ESMO) Asia 2016 Congress. Poster Presentation & Travel Award
2016 Japanese Society of Medical Oncology (JSMO) Annual Meeting. Oral Presentation & Travel Award
2015 河南省普通高等学校优秀毕业生
2014 研究生国家奖学金

研究方向
新型免疫治疗生物技术药物的研究与开发


代表性论著
1. Zhang X, Wang Y, Fan J, Chen W, Luan J, Mei X, Wang S, Li Y, Ye L,Li S, Tian W, Yin K*, Ju D*. Blocking CD47 efficiently potentiated therapeuticeffects of anti-angiogenic therapy in non-small cell lung cancer. Journal forImmunoTherapy of Cancer. 2019; 7:346.
2. Zhang X, Fan J, Ju D*. Insights into CD47/SIRPα axis-targetingtumor immunotherapy. Antibody Therapeutics. 2018; 1:37-42.
3. Zhang X, Chen W, Fan J, Wang S, Xian Z, Luan J, Li Y, Wang Y, NanY, Luo M, Li S, Tian W, Ju D*. Disrupting CD47-SIRPα axis alone or combinedwith autophagy depletion for the therapy of glioblastoma. Carcinogenesis. 2018;39:689-699.
4. Zhang X, Wang S, Nan Y, Fan J, Chen W, Luan J, Wang Y, Liang Y, LiS, Tian W, Ju D*. Inhibition of autophagy potentiated the anti-tumor effects ofVEGF and CD47 bispecific therapy in glioblastoma. Applied Microbiology and Biotechnology.2018; 102:6503-6513.
5. Zhang X, Luan J, Chen W, Fan J, Nan Y, Wang Y, Liang Y, Meng G, JuD*. Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3inflammasome activation and caspase-1-dependent pyroptosis. Nanoscale. 2018;10:9141-9152.
6. Zhang X, Fan J, Wang S, Li Y, Wang Y, Li S, Luan J, Wang Z, Song P,Chen Q, Tian W, Ju D*. Targeting CD47 and autophagy elicited enhancedanti-tumor effects in non-small cell lung cancer. Cancer Immunology Research.2017; 5:363-375. (Spotlight Research)
7. Zhang X, Gu Y, Chen T, Yang D, Wang X, Jiang B, Shao K, Zhao W,Wang C, Wang J, Zhang Q, Liu H*. Synthesis, in vitro and in vivo anticanceractivities of novel 4-substituted 1,2-bis(4-chlorophenyl)-pyrazolidine-3,5-dione derivatives. MedChemComm. 2015, 6:1781-1786.
8. Luan J, Zhang X, Wang S, Li Y, Fan J, Chen W,Zai W, Wang S, Wang Y, Chen M, Meng G, Ju D*. NOD-Like Receptor Protein 3Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis. Frontiers inImmunology. 2018; 9:758.
9. Chen W, Zhang X, Fan J, Zai W, Luan J, Li Y,Wang S, Chen Q, Wang Y, Liang Y, Ju D*. Tethering interleukin-22 toapolipoprotein A-I ameliorates mice from acetaminophen-induced liver injury.Theranostics. 2017; 7:4135-4148.